Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Closing the gap on antifungal resistance

Drug-resistant fungal disease must be addressed in the 2026 update to the Global Action Plan on Antimicrobial Resistance

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. WHO. Global Action Plan on Antimicrobial Resistance (2015).

  2. Denning, D. W. Lancet Infect. Dis. 24, e428–e438 (2024).

    Article  PubMed  Google Scholar 

  3. Lionakis, M. S. & Chowdhary, A. N. Engl. J. Med. 391, 1924–1935 (2024).

    Article  CAS  PubMed  Google Scholar 

  4. Song, Y. et al. Lancet Microbe 6, 101114 (2025).

    Article  CAS  PubMed  Google Scholar 

  5. Gupta, A. K. et al. J. Eur. Acad. Dermatol. Venereol. 40, 29–45 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  6. WHO. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action (2022).

  7. WHO. Landscape Analysis of Commercially Available and Pipeline In Vitro Diagnostics for Fungal Priority Pathogens (2025).

  8. WHO. Antifungal Agents in Clinical and Preclinical Development. Overview and Analysis (2025).

  9. van Rhijn, N. et al. Nat. Microbiol. 9, 29–34 (2024).

    Article  PubMed  Google Scholar 

  10. European Food Safety Authority (EFSA) et al. EFSA J. 23, e9200 (2025).

    Google Scholar 

Download references

Acknowledgements

We thank H. Sati for discussions and feedback on the manuscript. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Michaela Lackner.

Ethics declarations

Competing interests

Competing interests are declared in the Supplementary Information.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verweij, P.E., Alastruey-Izquierdo, A., Amilon, K. et al. Closing the gap on antifungal resistance. Nat Med (2026). https://doi.org/10.1038/s41591-026-04334-5

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41591-026-04334-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing